- Sector
- Healthcare
- Industry
- Health Information Services
- IPO Date
- Apr 3, 2020
Highlights
- Market Cap
- $387.16M
- Enterprise Value
- $4.99B
- EPS (TTM)
- -$17.33
- Total Revenue (TTM)
- $978.76M
- Gross Profit (TTM)
- $95.68M
- EBITDA (TTM)
- $368.77M
- Year Range
- $11.50 - $74.07
- Target Price
- $32.00
- ROA (TTM)
- -5.92%
- ROE (TTM)
- 118.82%
- Avg. Volume (1M)
- 98K
- Avg. Volume Value (1M)
- $2.73M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
CTEV Performance Chart
Claritev Corp (CTEV) is down 46.9% since the beginning of the year. At $23 per share, CTEV is trading 69.3% below its 52-week high of $74. Investors who bought $1,000 worth of CTEV shares 5 years ago would now be looking at an investment worth $71.
Loading charts...
Compare this symbol against anything
Returns By Period
Claritev Corp (CTEV) has returned -46.88% so far this year and -40.98% over the past 12 months.
Claritev Corp
- 1D
- -3.69%
- 1M
- -30.42%
- 6M
- -16.38%
- YTD
- -46.88%
- 1Y
- -40.98%
- 3Y*
- -35.74%
- 5Y*
- -41.16%
- 10Y*
- —
- ALL TIME*
- -36.12%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
CTEV Monthly Returns History
Based on dividend-adjusted daily data since Apr 3, 2020, CTEV's average daily return is +0.02%, while the average monthly return is -0.33%.
Historically, 46% of months were positive and 54% were negative. The best month was Dec 2024 with a return of +87.3%, while the worst month was Feb 2026 at -50.4%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 5 months.
On a daily basis, CTEV closed higher 47% of trading days. The best single day was Dec 24, 2024 with a return of +94.9%, while the worst single day was Feb 24, 2026 at -41.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -36.47% | -50.41% | 21.31% | 48.90% | 3.25% | 35.79% | -33.42% | -46.88% | |||||
| 2025 | 23.55% | 14.95% | -1.72% | 8.73% | 71.42% | 17.37% | -11.66% | 72.84% | -22.97% | 22.65% | -16.94% | -20.94% | 189.24% |
| 2024 | -29.86% | 10.89% | -27.57% | -19.90% | -17.37% | -27.66% | 15.89% | -47.79% | -18.72% | 17.28% | -11.94% | 87.33% | -74.34% |
| 2023 | 14.78% | -23.48% | 4.95% | -7.71% | 42.08% | 51.80% | 1.90% | -20.47% | -1.75% | 0.60% | -23.08% | 10.77% | 25.22% |
| 2022 | -9.03% | -6.70% | 24.47% | -5.34% | 12.87% | 9.80% | -7.83% | -30.43% | -18.75% | 0.35% | -48.08% | -22.82% | -74.04% |
| 2021 | -0.13% | -10.90% | -21.94% | 33.87% | 13.59% | 12.80% | -15.44% | -25.47% | -6.17% | -23.45% | -6.26% | 9.65% | -44.56% |
Benchmark Metrics
Claritev Corp has an annualized alpha of -15.58%, beta of 1.18, and R2 of 0.04 versus S&P 500 Index. Calculated based on daily prices since April 03, 2020.
- This stock participated in 176.81% of S&P 500 Index downside but only -24.69% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.04 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -15.58%
- Beta
- 1.18
- R²
- 0.04
- Upside Capture
- -24.69%
- Downside Capture
- 176.81%
Return for Risk
Risk / Return Rank
CTEV ranks 32 for risk / return — above 32% of stocks peers on PortfoliosLab. Its historical combined result is below the peer median.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Claritev Corp (CTEV) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CTEV | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.78 | ||
| Sortino ratioReturn per unit of downside risk | -1.75 | ||
| Omega ratioGain probability vs. loss probability | 1.03 | 1.25 | -0.22 |
| Calmar ratioReturn relative to maximum drawdown | -0.53 | 2.00 | -2.53 |
| Martin ratioReturn relative to average drawdown | -0.80 | 8.49 | -9.29 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Claritev Corp. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Claritev Corp was 98.91%, occurring on Nov 19, 2024. The portfolio has not yet recovered.
The current Claritev Corp drawdown is 95.26%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-98.91%Nov 2024 | 4y 4mo | — | 6y 14dJul 2020 - now | — |
-2.74%Jul 2020 | 2d | 5d | 7dJul 2020 - Jul 2020 | — |
-2.23%Jun 2020 | 4d | 8d | 12dJun 2020 - Jun 2020 | — |
-1.76%May 2020 | 1d | 15d | 15dMay 2020 - May 2020 | — |
-1.60%Jun 2020 | 2d | 4d | 6dJun 2020 - Jun 2020 | — |
Drawdown Indicators
| CTEV | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.91% | -56.78% | -42.13% |
Max Drawdown (1Y)Largest decline over 1 year | -81.44% | -9.10% | -72.34% |
Max Drawdown (3Y)Largest decline over 3 years | -93.83% | -18.90% | -74.93% |
Max Drawdown (5Y)Largest decline over 5 years | -98.32% | -25.43% | -72.89% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -95.26% | -1.58% | -93.68% |
Average DrawdownAverage peak-to-trough decline | -71.61% | -10.70% | -60.91% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 54.03% | 2.14% | +51.89% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Claritev Corp over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Claritev Corp is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for CTEV relative to other companies in the Health Information Services industry. Currently, CTEV has a P/S ratio of 0.4. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with CTEV
Add Claritev Corp to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with CTEV